Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jason Morton

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of the National Cancer Institute|June 30, 2023
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinomaCera Nieto, Bettina Miller, Nathaniel Alzofon, et al.
Cancer Research|August 21, 2020
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem CellsKarina E Gomez, FangLong Wu, Stephen B Keysar, et al.
Cancer Research|January 9, 2020
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous CarcinomaStephen B Keysar, Nathan Gomes, Bettina Miller, et al.
Cancer Research Communications|October 23, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma XenograftsJ Jason Morton, Stephan A Ramos, Nathaniel Alzofon, et al.
Molecular Cancer Research : MCR|October 22, 2020
Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse XenograftJ Jason Morton, Nathaniel Alzofon, Stephen B Keysar, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Cancer Research|April 12, 2013
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerStephen B Keysar, Phuong N Le, Ryan T Anderson, et al.
Journal of the National Cancer Institute|September 17, 2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2Stephen B Keysar, Phuong N Le, Bettina Miller, et al.
Molecular Oncology|April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular binsStephen B Keysar, David P Astling, Ryan T Anderson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the National Cancer Institute|June 30, 2023
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinomaCera Nieto, Bettina Miller, Nathaniel Alzofon, et al.
Cancer Research|August 21, 2020
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem CellsKarina E Gomez, FangLong Wu, Stephen B Keysar, et al.
Cancer Research|January 9, 2020
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous CarcinomaStephen B Keysar, Nathan Gomes, Bettina Miller, et al.
Cancer Research Communications|October 23, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma XenograftsJ Jason Morton, Stephan A Ramos, Nathaniel Alzofon, et al.
Molecular Cancer Research : MCR|October 22, 2020
Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse XenograftJ Jason Morton, Nathaniel Alzofon, Stephen B Keysar, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Cancer Research|April 12, 2013
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerStephen B Keysar, Phuong N Le, Ryan T Anderson, et al.
Journal of the National Cancer Institute|September 17, 2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2Stephen B Keysar, Phuong N Le, Bettina Miller, et al.
Molecular Oncology|April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular binsStephen B Keysar, David P Astling, Ryan T Anderson, et al.
Pageof 2